Single Peptides · Exact presentation
Vilon · 20 mg Vial
Vilon · 20 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 20 mg presentation, the reference concentration of 6.67 mg/mL mathematically corresponds to 2.999 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 6.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0667 mg at this concentration.
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
The source chart summarizes “67 mcg–667 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
| Phase / Cycle | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Cycle 1, Day 1 | 67 mcg (0.067 mg) | 1 unit (0.01 mL) |
| Cycle 1, Day 2 | 133 mcg (0.133 mg) | 2 units (0.02 mL) |
| Cycle 1, Day 3 | 200 mcg (0.20 mg) | 3 units (0.03 mL) |
| Cycle 1, Day 4 | 267 mcg (0.267 mg) | 4 units (0.04 mL) |
| Cycle 1, Day 5 | 333 mcg (0.33 mg) | 5 units (0.05 mL) |
| Cycle 2+ (Days 1–5) | 333–667 mcg (0.33–0.67 mg) | 5–10 units (0.05–0.10 mL) |
Reconstitution Steps
For a 20 mg presentation, the reference concentration of 6.67 mg/mL mathematically corresponds to 2.999 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 6.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0667 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It is described as a short peptide or bioregulator with proposed tissue-signaling effects. Mechanisms and targets are often less established than for well-characterized medicines.
Potential Benefits & Side Effects
Uncertainty about identity, pharmacology, efficacy, and safety is material. A biological hypothesis should not be presented as a demonstrated benefit.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Vilon · 20 mg Vial entrysecondary-structure
- PubMed — literature search for Vilonprimary-discovery
- ClinicalTrials.gov — study search for Vilontrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference